Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD
Status:
NOT_YET_RECRUITING
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
This is an open-label trial evaluating feasibility, tolerability, safety and efficacy of psilocybin assisted cognitive processing therapy for chronic Posttraumatic Stress Disorder (PTSD).
Phase:
PHASE2
Details
Lead Sponsor:
Unity Health Toronto
Collaborators:
Toronto Metropolitan University University of Ottawa